Go Pro

ProShares Ultra Nasdaq Biotechnology (BIB) Chart & Stock Price History

ProShares Ultra Nasdaq Biotechnology logo
$111.48 -2.42 (-2.13%)
As of 10:01 AM Eastern
This is a fair market value price provided by Massive. Learn more.

ProShares Ultra Nasdaq Biotechnology Stock Price Performance

The ProShares Ultra Nasdaq Biotechnology (BIB) fund chart highlights key performance trends across multiple timeframes. Over the last 12 months, the fund's price has increased 89.46%, with a year-to-date return of 39.73%. In the past month, the fund has decreased 0.49%, reflecting recent market activity.

As of the latest close, ProShares Ultra Nasdaq Biotechnology traded at $113.90 with a market cap of $92.26 million and volume of 3,987 shares. Five years ago, the fund traded at $106.80, representing a 4.38% increase over that period. At the time, it had a market cap of $309.72 million and a volume of 63,395 shares.

Receive BIB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ProShares Ultra Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
5 Day
Performance
+1.56%
1 Month
Performance
-0.49%
3 Month
Performance
+31.12%
Year-To-Date
Performance
+39.73%
1 Year
Performance
+89.46%
5 Year
Performance
+4.38%

BIB Stock Chart for Friday, September, 18, 2026

ProShares Ultra Nasdaq Biotechnology Stock Price History

DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
09/17/2026$108.99$113.90
+4.51%
$113.95$112.603,987 shs$92.26 million
09/16/2026$108.43$108.99
+0.51%
$110.50$107.513,759 shs$8.72 million
09/15/2026$111.73$108.43
-2.95%
$110.00$107.046,749 shs$8.67 million
09/14/2026$109.77$111.73
+1.79%
$112.38$109.955,271 shs$8.94 million
09/11/2026$109.60$109.77
+0.16%
$112.13$109.7714,721 shs$88.91 million
09/10/2026$112.81$109.60
-2.85%
$111.93$109.309,580 shs$88.78 million
09/09/2026$115.08$112.81
-1.97%
$115.19$112.6633,793 shs$91.38 million
09/08/2026$120.19$115.08
-4.25%
$117.00$113.429,330 shs$93.22 million
09/07/2026$120.19$120.19$121.57$119.635,967 shs$97.35 million
09/04/2026$121.91$120.19
-1.41%
$121.57$119.635,967 shs$97.35 million
09/03/2026$121.79$121.91
+0.10%
$121.95$120.143,486 shs$98.75 million
09/02/2026$118.55$121.79
+2.73%
$123.35$118.236,689 shs$98.65 million
09/01/2026$116.03$118.55
+2.17%
$118.55$115.476,773 shs$96.03 million
08/31/2026$116.39$116.03
-0.31%
$116.74$113.319,835 shs$93.98 million
08/28/2026$123.15$116.39
-5.49%
$122.92$116.0212,946 shs$94.28 million
08/27/2026$123.98$123.15
-0.67%
$123.81$121.2612,341 shs$99.75 million
08/26/2026$125.19$123.98
-0.97%
$124.51$123.483,903 shs$100.42 million
08/25/2026$120.91$125.19
+3.54%
$125.76$123.009,769 shs$101.40 million
08/24/2026$122.25$120.91
-1.10%
$123.15$118.5016,660 shs$97.94 million
08/21/2026$118.91$122.25
+2.81%
$124.11$120.7414,469 shs$99.02 million
08/20/2026$126.22$118.91
-5.79%
$122.73$118.7928,087 shs$96.31 million
08/19/2026$112.03$126.22
+12.67%
$126.40$117.2937,693 shs$102.24 million
08/18/2026$109.88$112.03
+1.96%
$112.29$109.9017,903 shs$90.74 million
08/17/2026$106.89$109.88
+2.80%
$109.91$105.5417,016 shs$89.00 million

This page (NASDAQ:BIB) was last updated on 9/18/2026 by MarketBeat.com Staff.
From Our Partners